NCT03871595View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 20, 2019

Primary Completion Date

April 24, 2019

Study Completion Date

April 24, 2019

Conditions
Healthy
Interventions
DRUG

BI 894416

3 tablets with 10 milligram (mg) of BI 894416 (total: 30 mg) were administered as one single oral dose with 240 milliliter (mL) of water.

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY